Who Paid My Doc
Rajit Basu
Pediatric Critical Care Medicine Atlanta, GA Medical Doctor
NPI 1366532566 CMS profile 1255956
1405 Clifton Rd Ne Fl 4, Atlanta, GA 30322
General payments
$55,032
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$13,650
Through program year 2025, Rajit Basu of Atlanta, GA is reported in the CMS Open Payments database as having received $55,032 across 65 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $13,650 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 99th percentile of Pediatric Critical Care Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
6 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $19,746 | 30 | |
| 2024 | General | $31,404 | 31 | |
| 2023 | General | $107 | 1 | |
| 2022 | General | $1,600 | 1 | |
| 2021 | General | $2,100 | 1 | |
| 2020 | General | $75 | 1 |
Beside peers
- Rajit Basu
- Pediatric Critical Care Medicine median
- Middle half of Pediatric Critical Care Medicine
- National median
In program year 2025, general payments to Rajit Basu were reported at $19,746. Among 471 Pediatric Critical Care Medicine profiles paid that year, the median was $72 and the middle half received between $29 and $177.
Show as a table
| Year | Rajit Basu | Pediatric Critical Care Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $76 | $21–$155 | $163 |
| 2020 | $75 | $48 | $21–$174 | $114 |
| 2021 | $2,100 | $41 | $19–$133 | $132 |
| 2022 | $1,600 | $76 | $25–$136 | $149 |
| 2023 | $107 | $76 | $25–$168 | $160 |
| 2024 | $31,404 | $73 | $24–$150 | $164 |
| 2025 | $19,746 | $72 | $29–$177 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
65 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Critical Care Medicine in Georgia
Jean Wright
Pediatric Critical Care Medicine · Savannah, GA
Renuka Mehta
Pediatric Critical Care Medicine · Augusta, GA
Vijay Srinivasan
Pediatric Critical Care Medicine · Atlanta, GA
Richard Cartie
Pediatric Critical Care Medicine · Augusta, GA
Smitha Mathew
Pediatric Critical Care Medicine · Augusta, GA
Brandon Kirkland
Pediatric Critical Care Medicine · Atlanta, GA
Related records
Pediatric Critical Care Medicine in Georgia
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Critical Care Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Georgia
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.